Unknown PHASE2 INTERVENTIONAL 2-arm NCT01658410

Short-term Endothelin A Receptor Blockade in Patients With On-pump CABG

Short-term Endothelin A Receptor Blockade in Patients With On-pump Coronary Artery Bypass Grafting

Sponsor: Medical University of Vienna

Conditions Aorto-coronary Bypass Grafting Coronary Artery Disease

Updated 6 times since 2017 Last updated: Aug 2, 2012 Started: Jul 31, 2012 Primary completion: Dec 31, 2015 Completion: Dec 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Aorto-coronary Bypass Grafting and Coronary Artery Disease, this trial is ongoing. The trial is conducted by Medical University of Vienna and has accumulated 6 data snapshots since 2012. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2
Feb 2017 — Jun 2018 [monthly]

Unknown Status PHASE2

Status: Enrolling By Invitation → Unknown Status

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Enrolling By Invitation PHASE2

First recorded

Jul 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Vienna

Data source: Medical University of Vienna

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Vienna, Austria